Bicycle Therapeutics (BCYC) PT Raised to $65 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $65.00 (from $47.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
